About Alfa Cytology
As a committed preclinical research service provider focused on cancer, Alfa Ctytology’s one-stop drug discovery services and a range of technology platforms will address the diverse needs of our clients, guaranteeing innovative and effective research results.
Learn MoreOne-Stop Bladder Cancer Therapy Development Service by Alfa Cytology
Alfa Cytology offers end-to-end preclinical development services for bladder cancer therapies, from disease modeling and diagnostic development to therapeutic evaluation, all under one roof.
Learn MoreHumanized Antibody Mouse Plus Single B Cell Technology for Antibody Discovery
By integrating an advanced humanized antibody mouse platform with single B-cell cloning technology, Alfa Cytology provides a full suite of services from discovery to lead antibody optimization. Clients can directly obtain fully human, high-affinity candidate antibody sequences...
Learn MoreDesigning Your Preclinical Cancer Modeling Mouse Studies
Alfa Cytology offers comprehensive preclinical mouse study design and execution services, from model selection to data analysis. Whether establishing PDX, CDX, or GEMM models or conducting efficacy, pharmacokinetic, and safety evaluations...
Learn MoreCell Line Derived Xenograft (CDX) Models Development for Preclinical Cancer Research
A robust and reproducible CDX model tailored for preclinical cancer research provides a reliable and cost-effective platform for initial drug screening, efficacy testing, and mechanistic studies, thereby accelerating...
Learn MoreReliable Diagnostic Development Services for Cancer
When it comes to cancer diagnostic development, Alfa Cytology stands out. We are committed to delivering reliable diagnostic solutions, from biomarker discovery and assay design to analytical validation and prototype development...
Learn More
